$2.780
+0.010 (+0.36%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Neuphoria Therapeutics Inc (NEUP) Moving Averages Convergence Divergence (MACD) indicator is -0.17, suggesting NEUP is Strong sell.
Neuphoria Therapeutics Inc (NEUP) 20-Day simple moving average is 3.22, while Neuphoria Therapeutics Inc (NEUP) share price is $—, making it Sell.
Neuphoria Therapeutics Inc (NEUP) 60-Day simple moving average is 3.55, while Neuphoria Therapeutics Inc (NEUP) share price is $—, making it Sell.
Technical Analysis for NEUP
AI Technical NEUPAs of 2026-11-07, the technical board for Neuphoria Therapeutics Inc (NEUP) reads strong sell: 2 indicators are flashing buy, 9 are indicating sell, and 2 are neutral. Price at $2.78 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 18.416, MACD stands at -0.174 (Sell), Stochastic %K stands at 5.619 (Buy), Stochastic %D stands at 3.673 and CCI stands at -168.626 (Buy).
NEUP trades below the 60-day SMA (3.55) and below the 200-day SMA (4.13). Immediate resistance sits at Classic R1 3.47, then R2 3.87. Support sits at Classic S1 2.69, then S2 2.31.
Neuphoria Therapeutics Inc (NEUP) Support & Resistance Level
Neuphoria Therapeutics Inc (NEUP) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 18.416 |
| STOCHk_14_3_3 | 5.619 |
| STOCHd_14_3_3 | 3.673 |
| CCI_20 | -168.626 |
| AO_5_34 | -0.433 |
| MOM_10 | -0.660 |
| MACD_12_26_9 | -0.174 |
Neuphoria Therapeutics Inc (NEUP) Relative Strength Index (RSI_14) is 18.416, creating a Buy signal.
Neuphoria Therapeutics Inc (NEUP) Stochastic %K is 5.619, creating a Buy signal.
Neuphoria Therapeutics Inc (NEUP) Stochastic %D is 3.673, creating a Buy signal.
Neuphoria Therapeutics Inc (NEUP) CCI_20 is -168.626, creating a Buy signal.
Neuphoria Therapeutics Inc (NEUP) Awesome Oscillator (AO) is -0.433, creating a Sell signal.
Neuphoria Therapeutics Inc (NEUP) Momentum (MOM) is -0.660, creating a Sell signal.
Neuphoria Therapeutics Inc (NEUP) Moving Average Convergence Divergence (MACD) is -0.174, creating a Sell signal.
Neuphoria Therapeutics Inc (NEUP) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 2.912 | Sell |
| MA_10 | 3.080 | Sell |
| MA_20 | 3.223 | Sell |
| MA_60 | 3.548 | Sell |
| MA_200 | 4.133 | Sell |
| MA_250 | 4.147 | Sell |
Neuphoria Therapeutics Inc (NEUP) 5-Day simple moving average is 2.912, while Neuphoria Therapeutics Inc (NEUP) share price is $, making it a Sell.
Neuphoria Therapeutics Inc (NEUP) 10-Day simple moving average is 3.080, while Neuphoria Therapeutics Inc (NEUP) share price is $, making it a Sell.
Neuphoria Therapeutics Inc (NEUP) 20-Day simple moving average is 3.223, while Neuphoria Therapeutics Inc (NEUP) share price is $, making it a Sell.
Neuphoria Therapeutics Inc (NEUP) 60-Day simple moving average is 3.548, while Neuphoria Therapeutics Inc (NEUP) share price is $, making it a Sell.
Neuphoria Therapeutics Inc (NEUP) 200-Day simple moving average is 4.133, while Neuphoria Therapeutics Inc (NEUP) share price is $, making it a Sell.
Neuphoria Therapeutics Inc (NEUP) 250-Day simple moving average is 4.147, while Neuphoria Therapeutics Inc (NEUP) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.